Clinical Trial Update: BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating BPC2001 for preventing acute graft-versus-host disease after haploidentical stem cell transplantation is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• BPC2001

Snippet

Sponsor: BioPhoenix Co., Ltd. | Conditions: Graft -Versus-host-disease, aGVHD | Phase 2 | Status: RECRUITING